How Chimeric Antigen Receptor Design Affects Adoptive T Cell Therapy-Reference-Cited by-同舟云学术

How Chimeric Antigen Receptor Design Affects Adoptive T Cell Therapy

Published:2016-06-02 Issue:12 Volume:231 Page:2590-2598
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Gacerez Albert T.¹,Arellano Benjamine¹,Sentman Charles L.¹

Affiliation:

1. Department of Microbiology and Immunology; Center for Synthetic Immunity; The Geisel School of Medicine at Dartmouth; One Medical Center Drive; Lebanon New Hampshire

Funder

Center for Synthetic Immunity

The Elmer R. Pfefferkorn & Allan U. Munck Education and Research Fund

NIH

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference89 articles.

1. Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells;Barber;Gene Ther,2011

2. Chimeric NKG2D expressing T cells eliminate immunosuppression and activate immunity within the ovarian tumor microenvironment;Barber;J Immunol,2009

3. Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma;Barber;Exp Hematol,2008

4. Chimeric antigen receptor therapy for cancer;Barrett;Annu Rev Med,2014

5. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia;Brentjens;Sci Transl Med,2013

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian network analysis of risk classification strategies in the regulation of cellular products;Artificial Intelligence in Medicine;2024-09

2. Targeting senescent cells with NKG2D-CAR T cells;Cell Death Discovery;2024-05-04

3. Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methods;mAbs;2024-04-18

4. 4-1BB Targeting Immunotherapy: Mechanism, Antibodies, and Chimeric Antigen Receptor T;Cancer Biotherapy and Radiopharmaceuticals;2023-09-01

5. Who wins the combat, CAR or TCR?;Leukemia;2023-08-25